Back to Directory Kira Bacon Email kbacon@frontierscience.org Institution Frontier Science Foundation Role Data Manager Address Frontier Science Foundation 4033 Maple Road Amherst, NY 14226 Request an Update Affiliated Studies IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum DAIDS Number 38609 Research Area Treatment Study Status Pending Locality US & Non-US IMPAACT 2032: Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States DAIDS Number 38746 Research Area Treatment Study Status Pending Locality United States P1026S: PK in Pregnancy DAIDS Number 10040 Research Area Treatment Study Status Closed to Follow Up Locality US & Non-US P1115: Very Early Intensive Tx on HIV-Infected Infants DAIDS Number 11954 Research Area Cure Study Status Enrolling Locality US & Non-US IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants DAIDS Number 20735 Research Area Cure Study Status Closed to Accrual Locality US & Non-US Show All
IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum DAIDS Number 38609 Research Area Treatment Study Status Pending Locality US & Non-US
IMPAACT 2032: Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States DAIDS Number 38746 Research Area Treatment Study Status Pending Locality United States
P1026S: PK in Pregnancy DAIDS Number 10040 Research Area Treatment Study Status Closed to Follow Up Locality US & Non-US
P1115: Very Early Intensive Tx on HIV-Infected Infants DAIDS Number 11954 Research Area Cure Study Status Enrolling Locality US & Non-US
IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants DAIDS Number 20735 Research Area Cure Study Status Closed to Accrual Locality US & Non-US